From research to entrepreneurship: the story of Laura Indolfi. How PanTher Therapeutics was born and the vision behind a new generation of oncological treatments.
Amid the dip, biotech execs share silver linings in a tumultuous environment
PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations
PanTher Initiates Phase 1b Clinical Trial of Absorbable, Long-Lasting, High-Dose Chemotherapy Patch for Pancreatic Cancer
